About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 277 record(s)
Req # A-2020-001024
Heath Canada’s documents that discussed the 2015 scheduling initiative pertaining to 2C-phenthylamines--especially the intended scope of substituted phenethylamines, and nomenclature for the intended substituted phenethylamines.Organization: Health Canada
December 2020
Req # A-2020-000657
All records regarding this article in The Logic: "Canadian tech companies that pivoted to making ventilators drawing global interest".Organization: Health Canada
December 2020
Req # A-2019-000092
Adverse Reaction Reports (AERs) for VEDOLIZUMAB. Report numbers: 717972, 720568, E2B_02098024, E2B_02110651, E2B_02135149, E2B_02136657, E2B_02159265, E2B_02165562, E2B_02168390, E2B_02171111, E2B_02187319, E2B_02188869, E2B_02201833, E2B_02210945,…Organization: Health Canada
December 2020
Req # A-2019-001066
Adverse Reaction Reports (AERs). Report numbers: 000643741, E2B_01509440, E2B_01969476, E2B_02062978, E2B_01466237, E2B_02107619, 00071681, 000718241, E2B_01651619, E2B_00583874, E2B_02103075.Organization: Health Canada
December 2020
Req # A-2019-001267
Adverse Reaction Reports (AERs). Report numbers: 000725284, 000725318, 000725522, 000726063, 000726157.Organization: Health Canada
December 2020
Req # A-2019-001321
Adverse Reaction Reports (AERs) for TUBERCULIN TEST. Report numbers: 0724435, 000726818, E2B_02561817, E2B_00420164.Organization: Health Canada
December 2020
Req # A-2019-001466
Adverse Reaction Reports (AERs). Report numbers: E2B_01944167, 000722663, 000722700, E2B_02490772, E2B_02316965, E2B_02370886, E2B_02328078, E2B_02386495, 000724940, 000729492, E2B_02442573, E2B_02388605, E2B_01947195, E2B_01919851, E2B_02391475,…Organization: Health Canada
December 2020
Req # A-2019-001658
Adverse Reaction Reports (AERs) for RIFAMPICIN. Report numbers: 000723664, 722459, E2B_02122906, E2B_02087388, E2B_01851601, E2B_02429179, E2B_02333618, E2B_02474319, E2B_02546192.Organization: Health Canada
December 2020
Req # A-2020-000596
Adverse Reaction Report (AER) for botulinum toxin. Report number: E2B_03123958.Organization: Health Canada
December 2020
Req # A-2019-001754
Adverse Reaction Reports (AERs) for LEFLUNOMIDE. Report numbers: E2B_02349992, E2B_02325750, E2B_02329666, E2B_02339085, E2B_02339140, E2B_02287925, E2B_02344561, E2B_02348416, E2B_02348417, E2B_02349027, E2B_02300724, E2B_02349040, E2B_02349041,…Organization: Health Canada
December 2020